Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DOCUSIGN, INC. director Brian Keith Roberts reported a compensation-related equity transaction involving restricted stock units. On June 5, 2026, 855 restricted stock units converted into 855 shares of common stock, leaving him with 855 common shares held directly.
The filing also shows 9,414 restricted stock units outstanding after the transaction. Each restricted stock unit represents a contingent right to receive one share of common stock and will vest in twelve equal quarterly installments over three years, starting on March 5, 2026, as long as Roberts remains a service provider. The units do not expire; they either vest or are canceled before vesting.
DocuSign director Anna Marrs reported an option exercise and a small share sale. On June 4, 2026, she exercised 725 restricted stock units, converting them into 725 shares of common stock at an exercise price of $0.00 per share. On June 5, 2026, she then executed an open-market sale of 363 common shares at $49.42 per share under a pre-arranged Rule 10b5-1 trading plan, leaving her with 12,977 common shares held directly after the transactions.
Docusign, Inc. reported solid first-quarter results with revenue of $830.2 million, up 9% from $763.7 million a year earlier, driven by growth in commercial and enterprise accounts and its digital channel. Subscription revenue remained about 98% of total.
Net income rose to $78.2 million, compared with $72.1 million, with diluted earnings per share of $0.40, up from $0.34. Operating income improved to $111.3 million, and GAAP gross margin held at 79.4%. International revenue increased 17% to $253.9 million and represented 31% of total revenue.
Operating cash flow was strong at $321.7 million, supporting free cash flow of $289.4 million. Docusign ended the quarter with about $1.0 billion in cash, cash equivalents and investments and no borrowings on its $750 million credit facility. The company repurchased 6.8 million shares for $318.4 million and has $2.4 billion remaining under its authorization. Its Intelligent Agreement Management offering represented 12.6% of total annual recurring revenue as of April 30, 2026. The income tax provision increased significantly to $39.6 million, reflecting higher pre-tax income and U.S. tax law changes under the One Big Beautiful Bill Act.
DOCU notice under Rule 144 reporting proposed resale of 363 shares of Common Stock by an issuer-related holder. The filing lists a restricted stock disposition dated 06/04/2026 and an earlier sale of 365 shares on 06/02/2026 by Anna Marrs. The broker-dealer on record is Morgan Stanley Smith Barney LLC.
Docusign, Inc. reported solid first quarter fiscal 2027 results, with revenue of $830.2 million, a 9% year-over-year increase including a 1.6 percentage-point boost from foreign exchange. GAAP gross margin held at 79.4%, while non-GAAP gross margin was 81.5% compared to 82.3% a year earlier.
GAAP diluted earnings per share were $0.40, up from $0.34, and non-GAAP diluted EPS rose to $1.09 from $0.90. Net cash from operations increased to $321.7 million, driving free cash flow of $289.4 million. The company ended the quarter with $1.0 billion in cash, cash equivalents, and investments and repurchased $317.5 million of common stock. Docusign also highlighted growing adoption of its AI-native Intelligent Agreement Management platform and issued guidance calling for mid- to high-single-digit revenue growth for the next quarter and fiscal year, alongside non-GAAP operating margins around 30%.
DOCUSIGN, INC. director Michael George Rosenbaum exercised restricted stock units into common shares. He acquired 522 shares of common stock through the conversion of 522 restricted stock units at a reported price of $0.0000 per share, with no shares sold in these transactions.
Following the exercise, he directly holds 1,566 shares of common stock and 4,699 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock, and the units vest in twelve equal quarterly installments over three years, subject to continued service.
Docusign, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Holders of 169,169,645 shares of common stock, representing approximately 87% of shares entitled to vote, were present, establishing a quorum.
Stockholders elected James Beer, Cain A. Hayes and Allan Thygesen to three-year terms ending at the 2029 annual meeting. They also ratified PricewaterhouseCoopers LLP as independent registered accounting firm for the fiscal year ending January 31, 2027.
On an advisory, non-binding basis, stockholders approved named executive officer compensation and supported holding future advisory votes on this compensation every year. A stockholder proposal requesting a report on risks of non-fiduciary executive compensation metrics did not receive approval.
DocuSign director Enrique T. Salem reported equity compensation activity. He received a grant of 4,384 restricted stock units (RSUs), each representing one share of common stock, vesting in equal quarterly installments over one year, tied to continued service.
On a separate date, he exercised 729 RSUs into 729 shares of common stock at no exercise price and did not report any same-day sale. After these transactions, he directly holds 167,318 shares of DocuSign common stock.
DocuSign director Enrique T. Salem reported equity compensation activity. He received a grant of 4,384 restricted stock units (RSUs), each representing one share of common stock, vesting in equal quarterly installments over one year, tied to continued service.
On a separate date, he exercised 729 RSUs into 729 shares of common stock at no exercise price and did not report any same-day sale. After these transactions, he directly holds 167,318 shares of DocuSign common stock.
DOCUSIGN, INC. director Teresa Briggs reported a mix of equity compensation and routine trading activity. She received a grant of 4,384 restricted stock units, each representing one share of common stock, which will vest in equal quarterly installments over one year, subject to continued service. On the same filing, she exercised 729 RSUs into common stock and sold 365 common shares at $50.04 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, she holds 10,263 common shares directly.
DOCUSIGN, INC. director Teresa Briggs reported a mix of equity compensation and routine trading activity. She received a grant of 4,384 restricted stock units, each representing one share of common stock, which will vest in equal quarterly installments over one year, subject to continued service. On the same filing, she exercised 729 RSUs into common stock and sold 365 common shares at $50.04 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, she holds 10,263 common shares directly.
DOCUSIGN, INC. director Mary Agnes Wilderotter reported routine equity compensation and estate-planning moves. She received a grant of 4,384 restricted stock units (RSUs) on June 1, 2026, each representing one share of common stock, vesting in equal quarterly installments over one year subject to continued service.
On May 29, 2026, she exercised 729 RSUs into 729 shares of common stock, bringing her directly held common stock to 3,199 shares. Earlier, on April 2, 2026, she made a bona fide gift of 57,333 shares of common stock to the Wilderotter Family Trust for no consideration. She serves as trustee, and she and her immediate family are the sole beneficiaries, so she continues to be the beneficial owner of those trust-held shares.
DOCUSIGN, INC. director Mary Agnes Wilderotter reported routine equity compensation and estate-planning moves. She received a grant of 4,384 restricted stock units (RSUs) on June 1, 2026, each representing one share of common stock, vesting in equal quarterly installments over one year subject to continued service.
On May 29, 2026, she exercised 729 RSUs into 729 shares of common stock, bringing her directly held common stock to 3,199 shares. Earlier, on April 2, 2026, she made a bona fide gift of 57,333 shares of common stock to the Wilderotter Family Trust for no consideration. She serves as trustee, and she and her immediate family are the sole beneficiaries, so she continues to be the beneficial owner of those trust-held shares.